L
$ Value
$12K
Shares
67
Price
$184
Filed
Feb 20
Insider
Name
Gregg Vicky B
Title
—
CIK
0001510304
Roles
Director
Transaction Details
Transaction Date
2026-01-28
Code
L
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
17,104
Footnotes
Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Filing Info
Gregg Vicky B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | DGX | L | $12K |
| 2025-11-25 | DGX | ▼ | $240K |
| 2025-10-21 | DGX | A | $13K |
| 2025-07-21 | DGX | L | $13K |
| 2025-05-29 | ACHC | A | $0 |
| 2025-05-15 | DGX | A | $0 |
| 2025-04-21 | DGX | A | $11K |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $1.1M | 2026-03-05 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $2.0M | 2026-03-05 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $7.0M | 2026-03-05 |
|
Davis J. E.
CEO and President
|
— | $2.1M | 2026-03-04 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-03-04 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-03-04 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | $538K | 2026-03-04 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-03-04 |